JAMA Neurology Journal

Overview
Identity
View All

publication venue for

Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage: The Global Burden of Disease Study 2021.. 82. 2025
Cardioprotective Glucose-Lowering Agents and Dementia Risk: A Systematic Review and Meta-Analysis.. 82:450-460. 2025
Immortal Time Bias and Nonlinear Stroke Recurrence Risk.. 82:527. 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical Trial.. 82:477-485. 2025
Safety and Efficacy of Tenecteplase Compared With Alteplase in Patients With Large Vessel Occlusion Stroke. 80:824-824. 2023
Effects of a Polypill, Aspirin, and the Combination of Both on Cognitive and Functional Outcomes. 80:251-251. 2023
Association of Genetic Variant Linked to Hemochromatosis With Brain Magnetic Resonance Imaging Measures of Iron and Movement Disorders. 79:919-919. 2022
Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source. 79:450-450. 2022
Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin. 78:1454-1454. 2021
Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis. 78:1333-1333. 2021
Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source. 78:11-11. 2021
A Pooled Analysis of Diffusion-Weighted Imaging Lesions in Patients With Acute Intracerebral Hemorrhage. 77:1390-1390. 2020
Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source. 77:1233-1233. 2020
Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes. 77:43-43. 2020
Left Atrial Enlargement Could Be Detected on Extended Computed Tomography Angiography Within Initial Stroke Assessment—Reply. 77:134-134. 2020
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation. 76:764-764. 2019
Association of Apolipoprotein E With Intracerebral Hemorrhage Risk by Race/Ethnicity. 76:480-480. 2019
Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. 76:301-301. 2019
Cerebral Microbleeds and the Effect of Intensive Blood Pressure Reduction on Hematoma Expansion and Functional Outcomes. 75:850-850. 2018
Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease. 73:431-431. 2016
Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy–Related Inflammation. 73:197-197. 2016
Rarity of the Alzheimer Disease–ProtectiveAPPA673T Variant in the United States. 72:209-209. 2015
Effects of Multiple Genetic Loci on Age at Onset in Late-Onset Alzheimer Disease. 71:1394-1394. 2014
Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease. 71:141-141. 2014
Direct-Acting Oral Anticoagulants. 70:1483-1484. 2013
Sex, Stroke, and Atrial Fibrillation. 69:1641-1641. 2012
Statins and Intracerebral Hemorrhage. 69:39-39. 2012
Postvaccination Miller Fisher Syndrome. 68:1327-1327. 2011
Possible Influence of Stroke Etiology on Hemorrhagic Transformation Following Thrombolysis in Warfarin-Treated Patients. 67:1413-1413. 2010
Measuring Demyelination and Remyelination in Acute Multiple Sclerosis Lesion Voxels. 66:375-381. 2009
Strategic Subcortical Hyperintensities in Cholinergic Pathways and Executive Function Decline in Treated Alzheimer Patients. 64:266-266. 2007
Presence of Alanine-to-Valine Substitutions in Myofibrillogenesis Regulator 1 in Paroxysmal Nonkinesigenic Dyskinesia. 62:597-597. 2005
Dementia With Lewy Bodies and the Neurobehavioral Decline of Mervyn Peake. 60:889-889. 2003
Plasticity, Hippocampal Place Cells, and Cognitive Maps. 58:874-874. 2001
Anticoagulation Therapy in Pediatric Patients With Sinovenous Thrombosis. 55:1533-1533. 1998
Prothrombotic Disorders in Infants and Children With Cerebral Thromboembolism. 55:1539-1539. 1998
Clinical Decision Making in Severe Brain Injury. 49:349-350. 1992
Duchenne Muscular Dystrophy Manifesting Carriers. 47:951-951. 1990
Cerebrospinal Fluid Somatostatin and Neuropeptide Y. 45:269-269. 1988
Therapeutic Range for the Control of Oral Anticoagulant Therapy. 43:1162-1164. 1986
Amyotrophic Lateral Sclerosis. 30:242-242. 1974
Multiple Muscle Analysis of Motor Units in Muscular Dystrophy. 30:249-251. 1974